UroGen Pharma (URGN) Change in Inventory (2017 - 2026)
UroGen Pharma's (URGN) quarterly Change in Inventory came in at $4.5 million in Q1 2026, up 372.27% YoY from $943747.1 in Q1 2025, and down 45.13% on a QoQ basis from $8.1 million in Q4 2025.
UroGen Pharma (URGN) Change in Inventory (2017 - 2026) Analysis & Trends
UroGen Pharma (URGN) has 9 years of Change in Inventory data on file, last reported at $4.5 million in Q1 2026.
- Quarterly Change in Inventory rose 372.27% year-over-year to $4.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.3 million (up 3741.79% YoY) and the FY2025 annual result came in at $7.2 million, up 103.63% from the prior year.
- Change in Inventory eased to $4.5 million in Q1 2026, from $8.1 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $8.1 million in Q4 2025 to a low of -$1.6 million in Q1 2025.
- A 5-year average of $997529.4 and a median of $199000.0 in 2024 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2023 — Change in Inventory jumped 1600.0% — and 2025, when it sank 332.16%.
- Tracing URGN's Change in Inventory over 5 years: stood at -$283000.0 in 2022, then jumped by 337.1% to $671000.0 in 2023, then surged by 143.37% to $1.6 million in 2024, then surged by 397.43% to $8.1 million in 2025, then tumbled by 45.13% to $4.5 million in 2026.
- The last three Change in Inventory figures came in at $4.5 million (Q1 2026), $8.1 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 47.15 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,188.52 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -280,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 12.97 Mn |
| 10 | UroGen Pharma | 2.36 Bn | 2.25 Bn | 65.88 Mn | 3.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.67 Mn |
| Jun 30, 2026 | 3.67 Mn |
| Mar 31, 2026 | 4.46 Mn |
| Mar 31, 2026 | 4.46 Mn |
| Dec 31, 2025 | 8.12 Mn |
| Dec 31, 2025 | 8.12 Mn |
| Sep 30, 2025 | 1.21 Mn |
| Sep 30, 2025 | 1.21 Mn |
| Jun 30, 2025 | -462,000.00 |
| Jun 30, 2025 | -462,000.00 |
| Mar 31, 2025 | -1.64 Mn |
| Mar 31, 2025 | -1.64 Mn |
| Dec 31, 2024 | 1.63 Mn |
| Dec 31, 2024 | 1.63 Mn |
| Sep 30, 2024 | 152,000.00 |
| Sep 30, 2024 | 152,000.00 |
| Jun 30, 2024 | 199,000.00 |
| Jun 30, 2024 | 199,000.00 |
| Mar 31, 2024 | 1.57 Mn |
| Mar 31, 2024 | 1.57 Mn |